US2020384199A1PendingUtilityA1
Computer Controlled Pediatric Regional Anesthesia
Est. expiryApr 7, 2037(~10.7 yrs left)· nominal 20-yr term from priority
A61B 5/24A61M 2202/048A61B 5/4848A61B 5/6837A61M 19/00A61B 5/6831A61B 5/4824A61M 2005/1405A61M 2005/1726A61M 5/1723A61M 5/14A61M 2230/08
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A drug delivery and monitoring device comprising a nerve stimulating element configured to deliver an electric stimulus, a recording element configured to detect a compound action potential, and a drug-delivery element.
Claims
exact text as granted — not AI-modifiedWe Claim:
1 . A drug delivery and monitoring device comprising:
(a) a nerve-stimulating element comprising a first electrode, wherein the first electrode is configured to deliver an electric stimulus; (b) a recording element comprising a second electrode, wherein the second electrode is configured to detect a compound action potential; and (c) a drug-delivery element located between the nerve-stimulating element and the recording element.
2 . The device of claim 1 , wherein said drug-delivery element comprises one or more of a suture guide, a drug output, a drug input, and a drug reservoir.
3 . The device of claim 1 , wherein said nerve-stimulating element comprises a stimulating echogenic needle.
4 . The device of claim 3 , wherein said echogenic needle is configured to deliver an electrical current directly to the nerve.
5 . The device of claim 4 , wherein said electrical current is between 1 and 10 amps.
6 . The device of claim 1 , further comprising a positioning element for securing the device to a nerve.
7 . A system, comprising:
(a) The device of claim 1 ; and (b) a computer device configured to record compound action potentials, make calculations based thereon, and control said drug-delivery element.
8 . The system of claim 7 , wherein the computer device is further configured to determine a drug dose based on said compound action potentials.
9 . The system of claim 8 , wherein a level of anesthesia is adjusted to keep the compound action potentials below a threshold level.
10 . The system of claim 9 , wherein said threshold level is 0.1 V.
11 . A method of delivering a regional drug to a subject, comprising:
a) contacting a nerve of the subject with the drug delivery and monitoring device of the system of claim 7 ; b) delivering the drug to the nerve using said system; and (c) monitoring compound action potentials; and (d) adjusting a level of the drug delivered to the nerve based on said compound action potentials.
12 . The method of claim 11 , wherein said drug is regional anesthesia.
13 . The method of claim 12 , wherein said regional anesthesia is epidural, spinal, or peripheral nerve block.Join the waitlist — get patent alerts
Track US2020384199A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.